This is a non-core endpoint: only basic statistics are computed.

Necrotizing enterocolitis of fetus and newborn

Endpoint Browser

P16_NECROTIZ_ENTEROCOLITIS_FETUS_NEWBO

No definition available.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P77 Cause of death: ICD-10 — P77 2 out of 7 registries used, show all original rules.	11
4. Check minimum number of events None	11
5. Include endpoints None	11
6. Filter based on genotype QC (FinnGen only)	7

Control definitions (FinnGen only)

Control exclude: P16_DIGES_SYSTEM_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P7[5-8]
Name in latin: Enterocolitis necroticans neonati

NAME	P16_NECROTIZ_ENTEROCOLITIS_FETUS_NEWBO
CONTROL_EXCLUDE	P16_DIGES_SYSTEM_DISORD_FETUS_NEWBO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P77
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P77
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Necrotizing enterocolitis of fetus and newborn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	508	203	305
Only index persons	185	77	108
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7	-	-
Unadjusted period prevalence (%)	0.00	-	-
Median age at first event (years)	0.00	-	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

7.12

2.11

2.6

13.1

2.24

2.84

g/l

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

6.51

1.99

2.4

11.3

137.60

163.69

—

(3036489) Thrombin time

6.51

1.99

2.4

11.8

23.60

23.15

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5.99

1.88

17.4

25.4

0.76

0.77

mmol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

5.14

1.68

7.0

10.8

84.40

83.50

—

(3013115) Eosinophils [#/volume] in Blood

+∞

1.51

10.8

19.4

0.17

0.22

e9/l

—

(3019198) Lymphocytes [#/volume] in Blood

+∞

1.51

10.7

17.7

2.91

3.33

e9/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3.94

1.34

13.6

22.4

5.66

4.28

mmol/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3.13

0.90

13.8

9.8

64.20

37.37

u/l

—

(3000991) Gas panel - Venous blood

2.82

0.85

13.0

11.3

—

(3044889) 12 lead EKG panel

2.55

0.79

4.6

2.0

—

(3002032) Base excess in Venous blood by calculation

2.21

0.54

10.0

19.9

0.14

0.17

mmol/l

—

(3024354) Oxygen [Partial pressure] in Venous blood

2.21

0.54

10.0

19.9

4.85

5.88

kpa

—

(3012544) pH of Venous blood

2.21

0.54

10.0

20.4

7.37

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.21

0.54

7.2

15.6

23.40

22.82

mmol/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2.21

0.54

10.0

20.0

6.04

5.57

kpa

—

(40761511) CBC panel - Blood by Automated count

+∞

0.45

42.3

9.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.45

0.0

2.5

—

(3003694) ABO and Rh group [Type] in Blood

1.56

0.29

3.4

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.23

0.0

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

0.00

0.22

0.0

9.5

—

591.69

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.0

3.8

—

6.09

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.0

3.6

—

1.49

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

7.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.0

3.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

4.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

4.8

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

0.00

-0.00

0.0

4.3

—

11.78

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.00

-0.00

0.0

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

2.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.00

-0.00

0.0

2.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

-0.00

0.0

2.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

0.00

-0.00

0.0

4.3

—

25.75

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

-0.00

0.0

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

5.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

-0.00

0.0

3.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

-0.00

0.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

41.22

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.7

—

11.07

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

-0.00

0.0

3.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_NECROTIZ_ENTEROCOLITIS_FETUS_NEWBO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_NECROTIZ_ENTEROCOLITIS_FETUS_NEWBO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_NECROTIZ_ENTEROCOLITIS_FETUS_NEWBO – Necrotizing enterocolitis of fetus and newborn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Necrotizing enterocolitis of fetus and newborn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints